Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 535

1.

Proteomic analysis of stratum corneum in Cutaneous T-Cell Lymphomas and psoriasis.

Méhul B, Ménigot C, Fogel P, Seraidaris A, Genette A, Pascual T, Duvic M, Voegel JJ.

Exp Dermatol. 2019 Jan 13. doi: 10.1111/exd.13880. [Epub ahead of print]

PMID:
30637808
2.

Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation.

Kim EJ, Aria AB, Wilmas K, Lewis DJ, Torres-Cabala CA, Nunez C, Dabaja BS, Duvic M.

Pediatr Dermatol. 2018 Dec 11. doi: 10.1111/pde.13728. [Epub ahead of print]

PMID:
30548331
3.

Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement.

Jensen GL, Dabaja BS, Pinnix CC, Gunther JR, Huen A, Duvic M, Oki Y, Fanale M, Hosing C, Milgrom SA.

Case Rep Oncol. 2018 Nov 12;11(3):721-728. doi: 10.1159/000494081. eCollection 2018 Sep-Dec.

4.

Antibody-Based Therapies for Cutaneous T-Cell Lymphoma.

Welborn M, Duvic M.

Am J Clin Dermatol. 2018 Nov 15. doi: 10.1007/s40257-018-0402-5. [Epub ahead of print] Review.

PMID:
30430444
5.

Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides.

Fountain E, Mistry H, Jain P, Duvic M, Fowler N.

Leuk Lymphoma. 2018 Oct 10:1-4. doi: 10.1080/10428194.2018.1516879. [Epub ahead of print] No abstract available.

PMID:
30301395
6.

High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.

de Jong A, Jabbari A, Dai Z, Xing L, Lee D, Li MM, Duvic M, Hordinsky M, Norris DA, Price V, Mackay-Wiggan J, Clynes R, Christiano AM.

JCI Insight. 2018 Oct 4;3(19). pii: 121949. doi: 10.1172/jci.insight.121949. [Epub ahead of print]

7.

Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients.

Lefrançois P, Xie P, Wang L, Tetzlaff MT, Moreau L, Watters AK, Netchiporouk E, Provost N, Gilbert M, Ni X, Sasseville D, Wheeler DA, Duvic M, Litvinov IV.

Oncoimmunology. 2018 May 31;7(8):e1467856. doi: 10.1080/2162402X.2018.1467856. eCollection 2018.

PMID:
30221071
8.

Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma.

Seto AG, Beatty X, Lynch JM, Hermreck M, Tetzlaff M, Duvic M, Jackson AL.

Br J Haematol. 2018 Nov;183(3):428-444. doi: 10.1111/bjh.15547. Epub 2018 Aug 20.

PMID:
30125933
9.

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators.

Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Erratum in: Lancet Oncol. 2018 Nov;19(11):e581.

PMID:
30100375
10.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2018 Jun 26. doi: 10.1093/annonc/mdy207. [Epub ahead of print] No abstract available.

PMID:
29947731
11.

Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure.

Chan WH, Lewis DJ, Kim EJ, Aung PP, Duvic M.

JAAD Case Rep. 2018 Feb 4;4(2):175-178. doi: 10.1016/j.jdcr.2017.09.006. eCollection 2018 Mar.

12.

Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma.

Lewis DJ, Huang S, Duvic M.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1652-1656. doi: 10.1111/jdv.15075. Epub 2018 Jun 8. Review.

PMID:
29775497
13.

Image Gallery: Symmetrical whirled eschars on the face in mycosis fungoides.

Lewis DJ, Kim EJ, Duvic M.

Br J Dermatol. 2018 Mar;178(3):e224. doi: 10.1111/bjd.16234. No abstract available.

PMID:
29595240
14.

Alopecia areata is a medical disease.

Korta DZ, Christiano AM, Bergfeld W, Duvic M, Ellison A, Fu J, Harris JE, Hordinsky MK, King B, Kranz D, Mackay-Wiggan J, McMichael A, Norris DA, Price V, Shapiro J, Atanaskova Mesinkovska N.

J Am Acad Dermatol. 2018 Apr;78(4):832-834. doi: 10.1016/j.jaad.2017.09.011. No abstract available.

PMID:
29548423
15.

The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study.

Gru AA, Kim J, Pulitzer M, Guitart J, Battistella M, Wood GS, Cerroni L, Kempf W, Willemze R, Pawade J, Querfeld C, Schaffer A, Pincus L, Tetzlaff M, Duvic M, Scarisbrick J, Porcu P, Mangold AR, DiCaudo DJ, Shinohara M, Hong EK, Horton B, Kim YH.

Am J Surg Pathol. 2018 Jun;42(6):726-734. doi: 10.1097/PAS.0000000000001041.

PMID:
29543675
16.

Successful Suppression of Recurrent Zosteriform Mycosis Fungoides With Maintenance Valacyclovir.

Lewis DJ, Hinojosa T, Chan WH, Wu JH, Duvic M.

Actas Dermosifiliogr. 2018 Oct;109(8):757-760. doi: 10.1016/j.ad.2017.09.023. Epub 2018 Feb 28. English, Spanish. No abstract available.

PMID:
29499833
17.

Eosinophilic infiltrate resembling eosinophilic cellulitis (Wells syndrome) in a patient with mycosis fungoides.

Emge DA, Lewis DJ, Aung PP, Duvic M.

Dermatol Online J. 2018 Jan 15;24(1). pii: 13030/qt9kq75581.

18.

Schnitzler syndrome in a patient with a family history of monoclonal gammopathy.

Wilmas K, Aria A, Torres-Cabala CA, Lu H, Duvic M.

Dermatol Online J. 2018 Jan 15;24(1). pii: 13030/qt41x7q1z5.

19.

Telangiectasia macularis eruptiva perstans: an old terminology, still frequently used.

Wilmas K, Wohlmuth-Wieser I, Duvic M.

Dermatol Online J. 2017 Aug 15;23(8). pii: 13030/qt6zx243zm. Review.

PMID:
29469737
20.

Pruritic arthropod bite-like papules in T-cell large granular lymphocytic leukaemia and chronic myelomonocytic leukaemia.

Lewis DJ, Miranda RN, Oh CW, Hinojosa T, Medeiros LJ, Curry JL, Tetzlaff MT, Torres-Cabala CA, Nagarajan P, Ravandi-Kashani F, Duvic M.

Clin Exp Dermatol. 2018 Jun;43(4):449-453. doi: 10.1111/ced.13401. Epub 2018 Feb 9.

PMID:
29423961
21.

Childhood alopecia areata-Data from the National Alopecia Areata Registry.

Wohlmuth-Wieser I, Osei JS, Norris D, Price V, Hordinsky MK, Christiano A, Duvic M.

Pediatr Dermatol. 2018 Mar;35(2):164-169. doi: 10.1111/pde.13387. Epub 2018 Jan 15.

PMID:
29334143
22.

How to Discern Folliculotropic Mycosis Fungoides From Follicular Mucinosis Using a Pediatric Case.

Emge DA, Lewis DJ, Aung PP, Duvic M.

J Cutan Med Surg. 2018 May/Jun;22(3):336-340. doi: 10.1177/1203475417752366. Epub 2018 Jan 10.

PMID:
29318909
23.

Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox.

Lewis DJ, Dao H Jr, Nagarajan P, Duvic M.

JAAD Case Rep. 2017 Oct 25;3(6):501-504. doi: 10.1016/j.jdcr.2017.06.031. eCollection 2017 Nov. No abstract available.

24.

Mycosis fungoides occurring at the site of previous herpes zoster eruption.

Huang S, Kim EJ, Lewis DJ, Chan WH, Miranda RN, Duvic M.

Australas J Dermatol. 2018 Aug;59(3):217-219. doi: 10.1111/ajd.12756. Epub 2017 Dec 26.

PMID:
29280139
25.

The Utility and Validity of the Alopecia Areata Symptom Impact Scale in Measuring Disease-Related Symptoms and their Effect on Functioning.

Mendoza TR, Osei J, Duvic M.

J Investig Dermatol Symp Proc. 2018 Jan;19(1):S41-S46. doi: 10.1016/j.jisp.2017.10.009.

26.

Important considerations for legislation banning commercial tanning beds among minors.

Lewis DJ, Duvic M.

Clin Dermatol. 2018 Jan - Feb;36(1):104-105. doi: 10.1016/j.clindermatol.2017.08.012. Epub 2017 Aug 31. No abstract available.

PMID:
29241746
27.

Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation.

Chan WH, Lewis DJ, Hinojosa T, Curry JL, Duvic M.

Pediatr Dermatol. 2018 Jan;35(1):e13-e16. doi: 10.1111/pde.13338. Epub 2017 Nov 21.

PMID:
29159918
28.

The "Duvic regimen" for erythrodermic flares secondary to Staphylococcus aureus in mycosis fungoides and Sézary syndrome.

Lewis DJ, Holder BB, Duvic M.

Int J Dermatol. 2018 Jan;57(1):123-124. doi: 10.1111/ijd.13832. Epub 2017 Nov 20. No abstract available.

PMID:
29152728
29.

Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma.

Smith GL, Duvic M, Yehia ZA, Allen P, Garg N, Suki T, Milgrom SA, Pinnix CC, Oki Y, Khoury JD, Dabaja BS.

Adv Radiat Oncol. 2017 Jun 15;2(3):363-369. doi: 10.1016/j.adro.2017.06.004. eCollection 2017 Jul-Sep.

30.

Differential expression of CCR4 in primary cutaneous gamma/delta (γ⁄δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy.

Jour G, Aung PP, Merrill ED, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Duvic M, Miranda RN, Torres-Cabala CA.

J Dermatol Sci. 2018 Jan;89(1):88-91. doi: 10.1016/j.jdermsci.2017.08.012. Epub 2017 Sep 1. No abstract available.

PMID:
29030090
31.

TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform.

Lefrançois P, Tetzlaff MT, Moreau L, Watters AK, Netchiporouk E, Provost N, Gilbert M, Ni X, Sasseville D, Duvic M, Litvinov IV.

Front Med (Lausanne). 2017 Sep 22;4:153. doi: 10.3389/fmed.2017.00153. eCollection 2017.

32.

Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results.

Lewis DJ, Talpur R, Huen AO, Tetzlaff MT, Duvic M.

JAMA Dermatol. 2017 Dec 1;153(12):1302-1306. doi: 10.1001/jamadermatol.2017.3593.

33.

ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways.

Ni X, Zhang X, Hu CH, Langridge T, Tarapore RS, Allen JE, Oster W, Duvic M.

Oncotarget. 2017 Jun 27;8(37):61761-61776. doi: 10.18632/oncotarget.18688. eCollection 2017 Sep 22.

34.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2017 Oct 1;28(10):2517-2525. doi: 10.1093/annonc/mdx352.

PMID:
28961843
35.

Generalised Eruptive Keratoacanthomas of Grzybowski.

Li JY, Lewis DJ, Duvic M.

J Cutan Med Surg. 2017 Sep/Oct;21(5):439. doi: 10.1177/1203475417711112. No abstract available.

PMID:
28920475
36.

Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma.

Lewis DJ, Kim YH, Duvic M.

Br J Dermatol. 2018 Jan;178(1):302-303. doi: 10.1111/bjd.15970. Epub 2018 Jan 10. No abstract available.

PMID:
28889405
37.

Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy.

Duvic M, Bates SE, Piekarz R, Eisch R, Kim YH, Lerner A, Robak T, Samtsov A, Becker JC, McCulloch W, Waksman J, Whittaker S.

Leuk Lymphoma. 2018 Apr;59(4):880-887. doi: 10.1080/10428194.2017.1361022. Epub 2017 Aug 30.

PMID:
28853310
38.

Novel Mutations Involving NF-κB and B-Cell Signaling Pathways in Primary Cutaneous Large B-Cell Lymphoma, Leg-Type and Comparison with Sézary Syndrome.

Kim EJ, Lewis DJ, Duvic M.

J Invest Dermatol. 2017 Sep;137(9):1831-1833. doi: 10.1016/j.jid.2017.06.013. Review.

39.

Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma.

Lewis DJ, Kim EJ, Duvic M.

Expert Opin Pharmacother. 2017 Oct;18(14):1535-1536. doi: 10.1080/14656566.2017.1367594. Epub 2017 Aug 18. No abstract available.

PMID:
28803489
40.

A possible association between mycosis fungoides and Muir-Torre syndrome: Two disorders with microsatellite instability.

Lewis DJ, Duvic M.

JAAD Case Rep. 2017 Jul 20;3(4):358-361. doi: 10.1016/j.jdcr.2017.04.007. eCollection 2017 Jul. No abstract available.

41.

Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma.

Winsett FT, Lewis DJ, Duvic M.

Expert Rev Hematol. 2017 Sep;10(9):757-760. doi: 10.1080/17474086.2017.1361819. Epub 2017 Aug 21. Review.

PMID:
28756726
42.

Oral bexarotene for post-transplant cutaneous T-cell lymphoma.

Lewis DJ, Huang S, Duvic M.

Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12524. Epub 2017 Jul 26.

PMID:
28748653
43.

Primary Cutaneous Peripheral T-Cell Lymphoma in a Sporotrichoid Pattern: A Case Report.

Lewis DJ, Vin H, Hinojosa T, Tetzlaff MT, Dabaja BS, Duvic M.

J Cutan Med Surg. 2017 Nov/Dec;21(6):568-571. doi: 10.1177/1203475417721425. Epub 2017 Jul 17.

PMID:
28712310
44.

An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone.

Lewis DJ, Turkeltaub AE, Dai J, Nagarajan P, Rieger KE, Nunez CA, Kim YH, Duvic M.

JAAD Case Rep. 2017 Jun 15;3(4):276-279. doi: 10.1016/j.jdcr.2017.03.001. eCollection 2017 Jul. No abstract available.

45.

Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.

Litvinov IV, Tetzlaff MT, Thibault P, Gangar P, Moreau L, Watters AK, Netchiporouk E, Pehr K, Prieto VG, Rahme E, Provost N, Gilbert M, Sasseville D, Duvic M.

Oncoimmunology. 2017 Mar 17;6(5):e1306618. doi: 10.1080/2162402X.2017.1306618. eCollection 2017.

46.

Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series.

Lewis DJ, Byekova YA, Emge DA, Duvic M.

J Dermatolog Treat. 2017 Sep;28(6):567-569. doi: 10.1080/09546634.2017.1294728. Epub 2017 Mar 2.

PMID:
28635518
47.

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.

Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M; ALCANZA study group.

Lancet. 2017 Aug 5;390(10094):555-566. doi: 10.1016/S0140-6736(17)31266-7. Epub 2017 Jun 7.

PMID:
28600132
48.

Curcumin for the treatment of tumor-stage mycosis fungoides.

Kim EJ, Lewis DJ, Dabaja BS, Duvic M.

Dermatol Ther. 2017 Jul;30(4). doi: 10.1111/dth.12511. Epub 2017 Jun 6. No abstract available.

PMID:
28585397
49.

Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.

Wieser I, Wang C, Alberti-Violetti S, Lyons G, Tran C, Talpur R, Duvic M.

Arch Dermatol Res. 2017 Aug;309(6):453-459. doi: 10.1007/s00403-017-1744-1. Epub 2017 May 17.

PMID:
28516243
50.

Forodesine in the treatment of cutaneous T-cell lymphoma.

Lewis DJ, Duvic M.

Expert Opin Investig Drugs. 2017 Jun;26(6):771-775. doi: 10.1080/13543784.2017.1324569. Epub 2017 May 5. Review.

PMID:
28447489

Supplemental Content

Support Center